Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Impact of Rosiglitazone on Regression of Atherosclerosis

This study has suspended participant recruitment.
(no fund)
Sponsor:
Collaborator:
National Science Council, Taiwan
Information provided by:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT00166803
First received: September 11, 2005
Last updated: January 2, 2009
Last verified: December 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: November 2008 (Final data collection date for primary outcome measure)